A case is presented of a very preterm neonate who developed severe cholestatic jaundice in association with prolonged parenteral nutrition. The effects of a therapeutic trial of phenobarbitone on bilirubin and liver enzymes are shown. This case suggests that phenobarbitone may have a role to play in the treatment of this condition, which is contrary to indications in a few other case reports in the literature. (Journal of Parenteral and Enteral Nutrition11:208-209, 1987)
Get full access to this article
View all access options for this article.
References
1.
Postuma R., Trevenen CL: Liver disease in infants receiving total parenteral nutrition. Pediatrics63:110-115, 1979
2.
Simon FR, Reichen J.: Bile secretory failure: Recent concepts in the pathogenesis of intra-hepatic cholestasis. IN Progress in Liver Disease, vol VII, Popper H, Shattner F (eds). Grune and Stratton, New York, 1982, pp 196-197
3.
Gleghorn EE, Merritt RJ, Subramanian NR, et al: Phenobarbital therapy does not decrease the incidence of parenteral nutrition cholestasis. Clin Res32:123A, 1982
4.
Cooper A., Ross AJ, O'Neill JA, et al: Resolution of intractable cholestasis associated with total parenteral nutrition following biliary irrigation. J Pediatr Surg20:772-774, 1985
